Prediction of GPCR activity using machine learning

GPCRs are the target for one-third of the FDA-approved drugs, however; the development of new drug molecules targeting GPCRs is limited by the lack of mechanistic understanding of the GPCR structure–activity-function relationship. To modulate the GPCR activity with highly specific drugs and minimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Prakarsh, Mollaei, Parisa, Cao, Zhonglin, Wang, Yuyang, Barati Farimani, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163700/
https://www.ncbi.nlm.nih.gov/pubmed/35685352
http://dx.doi.org/10.1016/j.csbj.2022.05.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163700/
https://www.ncbi.nlm.nih.gov/pubmed/35685352
http://dx.doi.org/10.1016/j.csbj.2022.05.016

Ejemplares similares